MedPath

Treatment of Obstructive Jaundice in Autoimmune Pancreatitis and/or Immunoglobulin G4-related Sclerosing Cholangitis by Corticosteroids

Not Applicable
Conditions
Autoimmune Pancreatitis
IgG4-related Sclerosing Cholangitis
Obstructive Jaundice
Interventions
Drug: corticosteroids
Procedure: biliary stent
Registration Number
NCT02797665
Lead Sponsor
Peking Union Medical College Hospital
Brief Summary

This study evaluates corticosteroids in the treatment of obstructive jaundice in autoimmune pancreatitis and/or immunoglobulin G4 (IgG4)-related sclerosing cholangitis in adults. Half of participants will receive corticosteroids alone, while the other half will receive corticosteroids with biliary stent at the beginning.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
30
Inclusion Criteria
  • adults greater than 18 years-old;
  • autoimmune pancreatitis and/or IgG4-related sclerosing cholangitis;
  • obstructive jaundice
Exclusion Criteria
  • malignancies; active infections;
  • pregnancy or breast feeding;
  • standard contraindications to ERCP;
  • unwillingness or inability to consent for the study

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Stent groupcorticosteroidsThe patients will be treated with oral corticosteroids and biliary stent.
Stent groupbiliary stentThe patients will be treated with oral corticosteroids and biliary stent.
Steroids groupcorticosteroidsThe patients will be treated with oral corticosteroids (prednisone 0.6mg/kg/d) alone.
Primary Outcome Measures
NameTimeMethod
Clinical remission rate of obstructive jaundiceDay 60
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Peking Union Medical College Hospital

🇨🇳

Beijing, Beijing, China

© Copyright 2025. All Rights Reserved by MedPath